• Women
  • Health Care Professionals
  • Our Mission
    • Resources
    • Donate
    • Avibela Project
  • Who We Are
    • Contact Us
    • Jobs
  • Our Team
    • Leadership
    • Board of Directors
    • Founder
  • Products & Pipeline
    • Clinic Locator
  • Updates
    • Blog
    • Press Releases
    • Publications
    • News
Close

Medicines360 is proud to make an important announcement about LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg

CLICK HERE TO READ THE PRESS RELEASE
Medicines360
  • Women
  • Health Care Professionals
Menu

Resource Category: Centers for Disease Control (CDC)

Unintended Pregnancy in the U.S.

November 29th, 2017 by David Kaiser-Jones

Learn about unintended pregnancy in the United States.

  • Posted in
  • Comments Off on Unintended Pregnancy in the U.S.

Recent Posts

  • Reflecting on Our Impact and Looking to the Future
  • New Survey Reveals Increasing Barriers for Women Seeking Birth Control and Disproportionate Impact on Women of Color
  • Healthcare Policies Must Work for Women, Not Against Them
  • Expanding Contraceptive Options Through an Institutional Patient Assistance Program
  • Statement on Reproductive Justice
Browse All
  • Women
  • Health Care Professionals
  • Our Mission
    • Resources
    • Donate
    • Avibela Project
  • Who We Are
    • Contact Us
    • Jobs
  • Our Team
    • Leadership
    • Board of Directors
    • Founder
  • Products & Pipeline
    • Clinic Locator
  • Updates
    • Blog
    • Press Releases
    • Publications
    • News
© 2021 Medicines360. A 501(c)(3) tax-exempt organization.
Medicines360® and its design are registered trademarks of Medicines360.
All other trademarks are property of their respective owners.
  • Privacy Policy
  • Terms of Use
  • Compliance
  • Community Guidelines
  • Contact Us

Please select one of the following:

I am a U.S. healthcare professional

I am not a U.S. healthcare professional

Zambia

Global Partners: WCG and Population Services International 

Madagascar

Global Partners: WCG and Population Services International 

Read the Press Release announcing the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Madagascar.